SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-322455
Filing Date
2021-11-08
Accepted
2021-11-08 09:04:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d254246ds3.htm S-3 374066
2 EX-1.2 d254246dex12.htm EX-1.2 196411
3 EX-4.5 d254246dex45.htm EX-4.5 307273
4 EX-5.1 d254246dex51.htm EX-5.1 30949
5 EX-5.2 d254246dex52.htm EX-5.2 5178
6 EX-23.1 d254246dex231.htm EX-23.1 1292
7 GRAPHIC g254246dsp139.jpg GRAPHIC 6890
8 GRAPHIC g254246dsp140.jpg GRAPHIC 2860
9 GRAPHIC g254246dsp145.jpg GRAPHIC 6977
10 GRAPHIC g254246dsp145a.jpg GRAPHIC 6093
11 GRAPHIC g254246g01g22.jpg GRAPHIC 54516
12 GRAPHIC g254246g01p04.jpg GRAPHIC 54502
  Complete submission text file 0001193125-21-322455.txt   1098965
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260859 | Film No.: 211386718
SIC: 8071 Services-Medical Laboratories